From the Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas (Wang, Montes de Oca, Koch, Al-Mohtaseb); Mercy Clinic Eye Specialists, Springfield, Missouri (Scott, Tauber).

Corresponding author: Zaina Al-Mohtaseb, MD, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin, NC 205, Houston, TX 77030. Email: [email protected].

Supported in part by the Sid W. Richardson Foundation, Fort Worth, Texas (L. Wang, D.D. Koch), SRB Charitable Corp., Fort Worth, TX (L. Wang, D. D. Koch), an unrestricted grant from Research to Prevent Blindness, New York, New York, and a Johnson & Johnson unrestricted grant (L. Wang, D.D. Koch, Z. Al-Mohtaseb).

Disclosures: L. Wang and Z. Al-Mohtaseb are consultants for Carl Zeiss Meditec AG and Alcon Laboratories, Inc. W. Scott and S. Tauber are consultants for Johnson & Johnson Vision. D.D. Koch is a consultant for Alcon Laboratories, Inc., Carl Zeiss Meditec AG, and Johnson & Johnson Vision.

First author:Li Wang, MD, PhDDepartment of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas